Anita Kuusela

The concept of actionability in genetics is frequently associated with identifying genetic variants that directly inform therapeutic intervention.  In pharmacogenomics, actionability often means using genetic information that may inform treatment selection and dosing for an individual.  Cholesterol management is an excellent example. … Read More »Actionability in Genomic Medicine: More Than Choosing the Right Drug

One question frequently asked is: “How many actionable genes do you report?” While this sounds like a simple question, it is really asking something much broader: “Under what circumstances can genomic information inform patient care?”  The true value of genomic testing is… Read More »Rethinking Clinical Actionability in Genomics